30.11.2012
- Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent...
23.11.2012
- Ranbaxy Laboratories, India's top drugmaker by sales, said it has recalled its cholesterol-lowering drug atorvastatin in the United States, a generic version of Lipitor that...
21.11.2012
- Indian drugmaker Cipla plans to offer $215 million for a majority stake in South Africa's Cipla Medpro to strengthen its presence in Africa's fast-growing market for cheap, generic...
20.11.2012
- New Markets - An estimated 25 million people in the U.S. suffer from rare diseases, known in the pharmaceutical industry as "orphan diseases". While the prevalence of each...
09.11.2012
- Swiss drugmaker Novartis's plant in Colorado, has just passed an inspection by U.S. regulators, giving it hope that quality control problems in its North American plants are being...
09.11.2012
- Canada's Supreme Court struck down the patent on global pharmaceuticals giant Pfizer's Viagra erectile dysfunction drug on Thursday and opened the door to generic competition. The...
03.11.2012
- India dealt a fresh blow to the international pharmaceutical industry on Friday as its patents appeal board revoked a patent granted six years ago on Roche's hepatitis C drug...
01.11.2012
- Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...
